Novartis Investigative Site

Perugia, Umbria 06156

0 studies enrolling now · 4 studies all time

What they study most

Metastases, Brain, Neoplasms, Breast, Ovarian Cancer

Studies at this site

• Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer — Completed
• Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING